Elon Musk Wants to Hack Your Brain
Publication/Creation DateAugust 5 2019
DescriptionWith Neuralink and other BCI companies pressing forward, the time has come for both regulators to take the technology seriously and industry to place patient protection at the center of innovation. Rather than uncontrollably accelerate innovation, the BCI industry will need to make a good faith effort to work with device regulators to protect patients. In turn, the FDA may need to pursue more flexible programs for speedy, yet safe innovation. Failure to compromise could instead lead to patient harm or exploitation under the guise of progress.
Date archivedAugust 7 2019
Last editedJuly 5 2021